Testosterone Cypionate Cost in Virginia (2026)

What Virginia Residents Actually Pay in 2026

The average cash price for a one-month supply of generic testosterone cypionate (200 mg/mL, 1 mL vial) at Virginia retail pharmacies sits near $60 in 2026. That figure applies to patients paying entirely out of pocket at chains like CVS, Walgreens, or Kroger locations across Northern Virginia, Richmond, Virginia Beach, and the Shenandoah Valley. Manufacturer list price for the same generic product runs about $100 per month, but few patients pay that rate.

Pricing varies by pharmacy. A Costco or Walmart in Fairfax County may price a 10 mL multi-dose vial (typically a 10-week supply at standard dosing) between $40 and $90, while an independent pharmacy in a smaller market like Roanoke or Lynchburg could charge $70 to $110 for the same vial. The Endocrine Society's 2018 clinical practice guideline recommends testosterone replacement for men with symptomatic hypogonadism confirmed by two morning serum testosterone levels below 300 ng/dL (1). That diagnostic threshold matters because it determines whether insurance or Medicaid will approve coverage, which in turn dictates whether a Virginia patient pays $60 or $5.

Branded Depo-Testosterone (the original reference product) is rarely stocked at Virginia pharmacies since multiple FDA-approved generics entered the market. If a pharmacy does carry the brand, expect $200 or more per month without insurance. Generic bioequivalence was established through FDA abbreviated new drug application standards, meaning the clinical effect is identical (2).

Virginia Medicaid Coverage

Virginia Medicaid covers testosterone cypionate with prior authorization for the diagnosis of male hypogonadism. The prior authorization process requires documentation of two serum total testosterone levels drawn before 10 a.m. on separate days, each below the laboratory's reference range (most Virginia labs use 264 to 916 ng/dL or 300 to 1 to 000 ng/dL as the normal range). The prescriber must also confirm that the patient has signs or symptoms consistent with testosterone deficiency.

Once approved, Medicaid beneficiaries in Virginia typically pay $0 to $3 per fill. Denials happen. The most common reason is a missing second confirmatory lab draw. If denied, the prescriber can submit a peer-to-peer review or an appeal with the additional documentation. Turnaround for initial PA decisions in Virginia is generally 24 to 72 hours for standard requests.

The T-Trials, a coordinated set of seven placebo-controlled trials enrolling 790 men aged 65 and older with serum testosterone below 275 ng/dL, showed that one year of testosterone gel treatment improved sexual function, physical function, and mood compared with placebo (3). Virginia Medicaid formulary committees reference data like the T-Trials when evaluating coverage criteria, which is why the diagnostic bar (confirmed low testosterone plus symptoms) remains firm. Testosterone cypionate was not the formulation used in the T-Trials (they used a gel), but the active hormone is identical once absorbed.

Commercial Insurance in Virginia

Most commercial insurers operating in Virginia, including Anthem Blue Cross Blue Shield, Aetna, Cigna, UnitedHealthcare, and Optima Health, place generic testosterone cypionate on Tier 1 or Tier 2 of their formularies. Typical copays range from $5 to $30 per month depending on the plan.

Prior authorization requirements vary. Some plans require it. Others do not for the generic injectable but do require PA for gels, patches, or nasal formulations. Virginia law does not mandate that private insurers cover testosterone replacement, but most do because the generic injectable is inexpensive relative to alternatives.

A 2020 analysis published in the Journal of the Endocrine Society found that injectable testosterone esters cost payers roughly one-tenth the annual expense of topical gel formulations, making the injectable the most cost-effective delivery method for testosterone replacement (4). Virginia patients who are prescribed a gel and face high copays should ask their provider about switching to the injectable, which almost always carries a lower out-of-pocket cost.

For patients on high-deductible health plans (HDHPs), the cash-pay price of roughly $60 per month may actually be less than the negotiated insurance rate applied to the deductible. In those cases, using a GoodRx or RxSaver coupon at a Virginia pharmacy and paying cash can be cheaper than running the claim through insurance until the deductible is met.

Compounded Testosterone Cypionate in Virginia

Compounded testosterone cypionate is legal in Virginia when dispensed by a state-licensed 503A compounding pharmacy with a valid patient-specific prescription. Virginia Board of Pharmacy regulations require that 503A pharmacies compound in response to individual prescriptions and comply with USP 797 sterile compounding standards.

The typical price for compounded testosterone cypionate in Virginia runs about $80 per month. That price is sometimes higher than the generic retail price, which surprises patients who assume compounded means cheaper. The advantage of compounding is customization: specific concentrations (e.g., 100 mg/mL for patients who need smaller-volume injections), combination products with anastrozole, or preservative-free formulations for patients with sensitivities.

One important distinction: 503B outsourcing facilities also operate in Virginia and can supply clinics with office-use stock. The FDA's 2023 guidance on 503B facilities tightened current good manufacturing practice (cGMP) expectations for sterile injectables (5). Patients receiving injections at a Virginia men's health clinic may be getting product sourced from a 503B facility rather than a traditional retail compounding pharmacy. Either route is legal, but patients should confirm the source if they have questions.

Not all insurance plans cover compounded medications. Virginia Medicaid generally does not reimburse for compounded testosterone cypionate when an FDA-approved generic is available and appropriate. Commercial plans vary, but most exclude compounded products from formulary coverage.

Telehealth Prescribing in Virginia

Virginia permits telehealth prescribing of testosterone cypionate. A prescriber licensed in Virginia can evaluate a patient via synchronous audio-video visit, order labs, and prescribe a Schedule III controlled substance without an in-person exam, provided the standard of care is met. The Virginia Board of Medicine's telemedicine regulations, updated in alignment with the Ryan Haight Act federal DEA requirements, allow this pathway.

For patients in rural parts of the state (Southwest Virginia, the Eastern Shore, parts of the Piedmont), telehealth eliminates the need to drive hours to see an endocrinologist or urologist. Virginia had 6.8 endocrinologists per 100,000 adults as of 2024 data from the Association of American Medical Colleges, below the national average of 8.1 (6). Telehealth closes that gap.

HealthRX and other telehealth platforms operating in Virginia can prescribe testosterone cypionate, order blood work through local Quest or Labcorp draw sites (both have extensive Virginia networks), and ship medication directly to the patient or send prescriptions to a local pharmacy. The entire process, from lab order to first injection, typically takes 5 to 10 business days.

After the DEA's 2025 final rule on telemedicine prescribing of controlled substances, providers must verify patient identity and conduct a real-time evaluation. Virginia-specific requirements do not add restrictions beyond the federal floor for testosterone prescribing via telehealth.

How to Get the Lowest Price in Virginia

Six concrete strategies reduce out-of-pocket cost for testosterone cypionate in Virginia.

Use the generic. Brand Depo-Testosterone costs three to four times more. Every Virginia pharmacy stocks the generic.

Compare pharmacy prices. Costco, Walmart, and some independent pharmacies in Virginia consistently price 10 mL vials 20% to 40% below CVS and Walgreens. A 10 mL vial at 200 mg/mL provides roughly 8 to 10 weeks of medication at a typical 200 mg weekly dose, bringing the per-month cost to $30 to $50 at the lowest-price pharmacies.

Use a discount card. GoodRx, RxSaver, and manufacturer savings programs can drop the price at some Virginia pharmacies below $40 for a 10 mL vial. These cards work for cash-pay patients and sometimes beat insurance copays.

Ask about multi-dose vials. The 1 mL single-dose vial costs more per milligram than the 10 mL multi-dose vial. If your dose and injection schedule allow it, the larger vial is more economical.

Check your insurance formulary. If you have commercial insurance, confirm that testosterone cypionate is on the formulary and whether PA is required. A single phone call to the number on the back of your insurance card can save weeks of delays.

Consider telehealth if you lack a local provider. Telehealth visits often cost $50 to $150 for the initial evaluation, but patients save on travel time, time off work, and specialist referral fees, particularly in rural Virginia.

A 2017 study in Translational Andrology and Urology reported that the average annual out-of-pocket cost for injectable testosterone was $120 to $240 for insured patients and $480 to $1,200 for uninsured patients nationally (7). Virginia's retail pricing in 2026 falls within the lower end of that uninsured range.

Testosterone Cypionate Dosing and Administration Basics

Standard dosing for testosterone cypionate in adult males with hypogonadism is 50 to 200 mg administered intramuscularly or subcutaneously every 7 to 14 days. The Endocrine Society guideline recommends titrating to a mid-normal serum testosterone level (typically 450 to 600 ng/dL measured at trough, just before the next injection) (1).

Many Virginia clinicians now prescribe twice-weekly subcutaneous injections using a 27-gauge insulin syringe. This approach produces more stable serum levels and fewer peaks and troughs compared with the traditional once-every-two-weeks intramuscular protocol. A 2014 pharmacokinetic study in the Journal of Clinical Endocrinology and Metabolism demonstrated that subcutaneous administration of testosterone cypionate produced bioequivalent serum testosterone levels to intramuscular injection, with lower peak-to-trough variability (8).

Patients in Virginia should also know that testosterone cypionate is classified as a Schedule III controlled substance under both federal law and Virginia Code § 54.1-3448. Prescriptions can be written for up to a 90-day supply with refills, but pharmacies will verify the DEA number and may require identification at pickup. Virginia does not require patients to register with the state's Prescription Monitoring Program (PMP), but prescribers are required to check the PMP before issuing controlled substance prescriptions.

Monitoring and Follow-Up Costs

The medication itself is only part of the total cost. Virginia patients on testosterone replacement also need periodic blood work. The Endocrine Society recommends checking serum testosterone, hematocrit, and PSA at 3 to 6 months after starting therapy, then annually (1). A basic testosterone and CBC panel through Quest Diagnostics or Labcorp in Virginia costs $50 to $150 without insurance. With insurance, it is typically covered as preventive or diagnostic lab work with a $0 to $25 copay.

Hematocrit monitoring is non-negotiable. The TRAVERSE trial (N=5,246), published in The New England Journal of Medicine in 2023, found that testosterone replacement was associated with a higher incidence of atrial fibrillation and polycythemia compared with placebo, though major adverse cardiovascular events did not differ significantly between groups (9). Virginia prescribers who follow current guidelines will check hematocrit regularly and may recommend therapeutic phlebotomy or dose reduction if hematocrit exceeds 54%.

The TRAVERSE data also led the FDA to update the testosterone product labeling in 2024 to include information about cardiovascular risks, reinforcing the importance of prescribing testosterone only for confirmed hypogonadism rather than age-related decline alone (10).

Virginia-Specific Regulatory Notes

Virginia does not impose state-level restrictions on testosterone cypionate prescribing beyond federal DEA requirements. The Virginia Board of Medicine does not require a specialist referral for testosterone prescriptions. Any Virginia-licensed physician, nurse practitioner, or physician assistant with prescriptive authority for Schedule III substances can prescribe testosterone cypionate.

Virginia also does not have a state-mandated age minimum for testosterone replacement beyond the standard of care (adult males with confirmed hypogonadism). Testosterone replacement in adolescent males with delayed puberty or Klinefelter syndrome is managed by pediatric endocrinologists, typically at academic centers like UVA Health or VCU Health.

For patients relocating to Virginia or splitting time between Virginia and another state, prescriptions written by an out-of-state provider can be filled at Virginia pharmacies as long as the prescriber holds a valid DEA registration and the prescription meets Virginia Prescription Monitoring Program requirements. Telehealth prescribers must be licensed in Virginia to treat patients physically located in the state at the time of the encounter.